ROBERT L MARSH M.D. NPI 1730157371

NPI Details

Robert L Marsh, M.D. is a hematology and oncology internal medicine in Gainesville, VA with 49 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Robert L Marsh, M.D. NPI is 1730157371. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7901 LAKE MANASSAS DR
GAINESVILLE, VA
ZIP 20155-257
Phone: (571) 222-2200
Fax: (571) 222-2202

The NPI 1730157371 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Nephelometry, test method using light (HCPCS:83883)
• Unclassified drugs (HCPCS:J3490)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Protein measurement, serum (HCPCS:84165)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Urinalysis, manual test (HCPCS:81002)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Refilling and maintenance of portable pump (HCPCS:96521)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Uric acid level, blood (HCPCS:84550)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Total protein level, blood (HCPCS:84155)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 3/9/2006 and was last updated on 10/24/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.